After ABX treatment, no differences in weight loss, colon length, or clinical disease score were observed between WT and slamf7-/- mice (Figure S7c-e), indicating a relationship between the intestinal microbiota and SLAMF7-mediated exacerbation of colitis. This evidence concerns the gene SLAMF7 and colitis.